Chapter 37: Female Reproductive System Physiology

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

Female Reproductive System Physiology provides a comprehensive physiological analysis of the female reproductive system, centering on the complex integration of the hypothalamic-pituitary-ovarian axis that regulates fertility and the menstrual cycle. It explores the pulsatile secretion of gonadotropin-releasing hormone (GnRH) and its role in stimulating the anterior pituitary to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn control ovarian steroidogenesis. The text elucidates the stages of folliculogenesis, from primordial follicles to the mature Graafian follicle, and explains the two-cell, two-gonadotropin hypothesis where theca cells produce androgens under LH stimulation, which are then converted to estradiol by FSH-stimulated granulosa cells. Key physiological events such as the positive feedback mechanism of estradiol leading to the midcycle LH surge, ovulation, and the resumption of meiosis are described in depth. The chapter further examines the luteal phase, detailing the formation of the progesterone-secreting corpus luteum and its regression (luteolysis) in the absence of fertilization. These ovarian events are correlated with the endometrial cycle, distinguishing between the proliferative, secretory, and menstrual phases of the uterus, alongside cyclic changes in the cervix and vagina. Additionally, the material covers the life-cycle transitions of puberty (including gonadarche, thelarche, and adrenarche) and menopause, characterizing the latter by follicular depletion and elevated gonadotropins. Finally, the chapter addresses clinical pathophysiology, including infertility, amenorrhea, polycystic ovarian syndrome (PCOS), and precocious puberty, while discussing therapeutic interventions like Hormone Replacement Therapy (HRT) and Selective Estrogen Receptor Modulators (SERMs) for managing menopausal symptoms and osteoporosis.